This month, Cryo-EM provided new insights into the vitamin K enzyme, as well as channel and GPCR...
cryoDuck Hottest Social in SBDD (04/2025)
April delivered no shortage of turbulence — but also a few genuine bright spots.
Amid ongoing instability across biotech and science funding, OpenAI’s rumored plans to launch an X/Twitter alternative offered a rare flash of optimism for online scientific communities. Cryo-EM, quite literally, got even cooler with the rebirth of helium-cooled microscopes. CryoSPARC 4.7 arrived with meaningful workflow improvements, while Thermo Fisher leaned into corporate cinema flair, promoting the new Krios 5 against sweeping jungle backdrops and scenes of children playing in the dusts of Africa. And in a moment that neatly captured the broader mood: the 3DEM mailing list collapsed into an infinite loop of out-of-office auto-replies.
BlueSky cryo-EM & biotech
A large, general and modular DARPin-apoferritin scaffold enables the visualization of small proteins by cryo-EM pubmed.ncbi.nlm.nih.gov/40277178/ #cryoEM
— cryoEM papers (@cryoempapers.bsky.social) April 26, 2025 at 2:55 PM
New SLC33A1 cryo-EM structure in Cell Discovery, unlocked by Salipro®! The study reveals key drug discovery insights for neurodegeneration & cancer. Great work by the authors! Full study: www.nature.com/articles/s41... #Salipro #CryoEM #SLC33A1 #DrugDiscovery #MembraneProtein #StructuralBiology
— Salipro Biotech (@saliprobiotech.bsky.social) April 25, 2025 at 11:40 AM
[image or embed]
🦠🧠 MemBrain update! 🧠🦠 We've updated our preprint! It now covers the full MemBrain v2 pipeline for end-to-end membrane analysis in #CryoET: segmentation, particle picking, and spatial statistics. 🔗 Preprint: doi.org/10.1101/2024... 🔗 Code: github.com/CellArchLab/... 🧵(1/6) #TeamTomo
— Lorenz Lamm (@lorenzlamm.bsky.social) April 25, 2025 at 9:28 AM
[image or embed]
📜 Transport of phenoxyacetic acid herbicides by PIN-FORMED auxin transporters 🧑🔬 @lukas-schulz.bsky.social, @unglam.bsky.social, @bjornppedersen.bsky.social, @uhammes.bsky.social, et al. 📔 @natplants.nature.com 🔗 www.nature.com/articles/s41... #️⃣ #PlantScience #Phytohormones #Auxin #CryoEM
— Marc Somssich (@somssich.bsky.social) April 25, 2025 at 9:23 AM
[image or embed]
Nickel-NTA lipid-monolayer affinity grids allow for high-resolution structure determination by cryo-EM www.biorxiv.org/content/10.1101/2025.04.24.650495v1 #cryoEM
— cryoEM papers (@cryoempapers.bsky.social) April 25, 2025 at 9:10 AM
Enjoyed this newly-published guide to Cryo-EM for battery research! Some great points to think about when aiming to make battery EM as quantitative as possible.
— electro-them-istry 🏳️🌈 (@electro-them-istry.bsky.social) April 24, 2025 at 10:52 PM
[image or embed]
Simultaneous polyclonal antibody sequencing and epitope mapping by cryo electron microscopy and mass spectrometry pubmed.ncbi.nlm.nih.gov/40266252/ #cryoEM
— cryoEM papers (@cryoempapers.bsky.social) April 24, 2025 at 10:35 PM
We have determined the first #cryoEM structures of human GlyT2 bound to a potent pseudo-irreversible inhibitor (ORG25543) that failed in pre-clinical studies, a novel and reversible inhibitor (RPI-GLYT2-82), and in the substrate-free state.
— Azadeh Shahsavar (@azadeh-shahsavar.bsky.social) April 24, 2025 at 10:14 PM
[image or embed]
This structure is absolutely _nuts_. Lipids are captured marching through the tunnel
— Diego del Alamo (@delalamo.xyz) April 26, 2025 at 12:02 PM
[image or embed]
Do you want to visualize motion in protein structures? I've used @chimerax.ucsf.edu and little python code to do just that github.com/schaefer-jh/.... Here is some ABC transporter magic. #LLM assisted #coding
— Jan-Hannes Schaefer (@jhschaef.bsky.social) April 24, 2025 at 10:05 PM
[image or embed]
Am having a whale of a time at the @ccpem.bsky.social Spring Symposium today! I have hung out with other crowds too recently, but it's good to be reminded how much fun Structural Biology conferences are. Atomic structure has a beautiful definitiveness to it: it is what it is. 🤗
— Sjors Scheres (@sjorsscheres.bsky.social) April 24, 2025 at 6:27 PM
I'm excited to share our lab's newest publication on the structure and pharmacology of human GABA transporter 3 @natcomms.nature.com. Much to our surprise, GAT3 adopts an inward-open conformation in complex with the (moderately) selective antagonist SNAP-5114. 💊 🧪 #CryoEM #OpenAccess rdcu.be/ei2KY
— Cornelius Gati (@gati.bsky.social) April 23, 2025 at 11:37 PM
[image or embed]
Social media has been great in helping us identify contaminants or cofactors in the past - Any ideas what this complex might be in our HEK293 FLAG pulldown? (We should put together a repository of common contaminants in different cell types)
— Lander Lab (@landerlab.bsky.social) April 21, 2025 at 7:26 PM
[image or embed]
Indeed very cool work, and nothing beats the looks of the Polara to illustrate it!
— Lars-Anders Carlson (@lacarlson.bsky.social) April 23, 2025 at 10:55 AM
[image or embed]
X/Twitter cryo-EM & biotech
3DEM mailing list is on an infinite loop of one researcher's vacation autoreply sending an OOO message, which the listserv sends to the whole world including that researcher, who then autoreplies with OOO, which the listserv then sends to the world incl that researcher, who then—
— Jason Kaelber (@Kaelberviridae) April 21, 2025
Lilly's oral GLP-1 drug delivers Ozempic-like efficacy in phase 3 diabetes trial https://t.co/k431yCjzel
— Cheers (@raintank2010) April 17, 2025
Jonathan Norris of HSBC, told Endpoints that he counted 47 financings (Seed/Series A) for biopharma companies in the US/EU in the 1st qtr. Of the $2.6B he tallied, $1.9B went to just 6 companies, including a massive $600M bet on Alphabet's Isomorphic Labs
— Paras Sharma (@paras_biotech) April 18, 2025
Source: Endpoints pic.twitter.com/jLA77Tp1s1
BREAKING: OpenAI, the parent company of ChatGPT, is reportedly working on launching their own "X-like" social media platform.
— The Kobeissi Letter (@KobeissiLetter) April 15, 2025
GLP-1 Agonists: A New Frontier in Addiction Treatment? Beyond diabetes/obesity, GLP-1R agonists reduce alcohol intake, motivation, and relapse in preclinical + human studies. Genetics tie GLP-1R to AUD risk. Mechanism may involve reward circuits + brainstem pathways. Could… pic.twitter.com/KRGLHYW8D6
— Scott Isaacs (@scottisaacsmd) April 15, 2025
I'm happy to share our recent manuscript in which we are structurally and biochemically investigating 3'-5' tRNA splicing ligases, including a #cryoEM structure of the five-subunit D. rerio tRNA ligase complex.https://t.co/VtfbOrx5u5 pic.twitter.com/giUo2eCtdC
— Mariusz Czarnocki-Cieciura (@MariuszCzC) April 15, 2025
From Stifel: The most valued Biotechs are those with "Very Good" Ph3 data
— Paras Sharma (@paras_biotech) April 13, 2025
"even companies with a very good dataset have traded down in the last 8 weeks. One interpretation of this is that with forced selling in the market, funds have had no choice but to sell their best silver" pic.twitter.com/5RdwEMTCVt
Overview of clinical evidence for sex-specific effects of GLP-1 analogs and their potential interaction with estrogens. GLP-1 analogs are reshaping diabetes and obesity care, but sex differences in their effects are emerging. Women may experience distinct benefits and side… pic.twitter.com/QEdzXij4wi
— Scott Isaacs (@scottisaacsmd) April 12, 2025
Biotech Venture Creation: The Benefits Of Scarcity.
— Bruce Booth (@LifeSciVC) April 8, 2025
The equity markets have collapsed in 2025, the IPO window is closed, the FDA is in turmoil, the NIH is being gutted… and it's a great time to start new biotech companies.https://t.co/iDN3NSLCT5 pic.twitter.com/mt8uECYLzc
🚨 Can we stop the offshoring of U.S. biotech?
— Benjamin L. Oakes (@BenjaminLOakes) April 8, 2025
A Senate report dropped today with a clear warning: U.S. biotech is at risk of falling behind as China's state-backed sector rapidly accelerates. While there's a lot of analysis in the report I see one major trend it misses:
👉…
#CryoSPARC v4.7 is out! 🚀
— Structura Biotechnology (@structurabio) April 9, 2025
Featuring a new automatic Micrograph Junk Detector that labels and rejects contaminants, new tools for curating subsets of particles, performance and stability fixes, and more!
Full changelog: https://t.co/M3mLGtFhSS#cryoEM pic.twitter.com/QI3GnY0Qmm
New paper from our lab just out @PNASNews! 🚀
— Giulia Palermo (@palermo_lab) April 2, 2025
Using free energy simulations, #AIphaFold and #cryoEM refinement, we uncovered a key conformational change in a paradigm-shifting #CRISPR-associated #transposon capable of precise gene knock-ins. 🔍🧬https://t.co/E6vLAw0igx pic.twitter.com/eBNIZayEG2
🔬 New from the Farnung Lab: We have established a fully in vitro reconstituted chromatin replication system and we report the first cryo-EM snapshots of the human replisome engaging nucleosomes. 🧬✨https://t.co/Ox7gJYtUyL pic.twitter.com/HlMV3MYBlM
— Lucas Farnung (@LucasFarnung) April 6, 2025
Absolute BLOODBATH at HHS/NIH/CDC this morning. Generation of scientists, health care officials being wiped out pic.twitter.com/ikJjcOiqhp
— Sam Stein (@samstein) April 1, 2025
Good! Too many bad undifferentiated and diluted ideas got funded the past 10 years. Sector deserves every bit of pain it is experiencing.
— Dr. Paul De Santis, PharmD (@DrPaulyDeSantis) March 31, 2025
#1 Biotech in Europe?
— BowTiedBiotech 🧪🔬🧬 (@BowTiedBiotech) March 30, 2025
🇪🇺 $ARGX - Argenx leads the pack with a $35B market cap
That's ahead of some big-name U.S. biotechs:
🔹$ALNY (Alnylam) - ~$34B
🔹$IONS (Ionis) - ~$5B
🔹$BBIO (BridgeBio) - ~$6B
🔹$BEAM (Beam) - ~$2B$ARGX > $IONS + $Beam + $BBIO COMBINED
Seriously.
The… pic.twitter.com/gE6VtMTmEW
people will be like "that looks cool! what prompt did you use?" pic.twitter.com/iCIFO2juC2
— eryney marrogi (@eryney_ok) March 29, 2025
Very excited to share our recent study on the chemokine receptors, highlighting the dual-agonism in CXCR3-CXCR7 system. Many congratulations to all involved! @arshukla @saha_shirsha ✨✨ https://t.co/Nogf198r25
— Saloni Sharma (@_SaloniSharma_) March 28, 2025
SPACEtomo v1.3 is now available! What's new?
— Fabian (@EisFabian) March 28, 2025
- Lots of tools for setting up targets on non-lamella samples
- Option for reacquisition of specific maps (e.g. after cleaning)
- Bug fixes and more robust
Give it a try and let me know what is still missing!https://t.co/3GO6qP9raz pic.twitter.com/guWowJR8gg
Just find the recording of this symposium is on YouTube
— Rui Zhang (@RuiZhangWUSTL) March 25, 2025
Cryo-EM: The Next 50 Years Symposiumhttps://t.co/YawfJsCwnD
The basic installation of @OISTedu's new @JEOL_Japan cryoARM 300 and 200 is now complete! 😍 pic.twitter.com/NR73pzp4vh
— Wolf Lab (@HiCryoEM) March 26, 2025
Happy to share our work on the allosteric regulation of FFA2 receptors! It was a great collab. with the Ishikita, @DrorLab, and @TohokuSeika labs. Congrats to Mai, @kk_kawakami, Ryoji, and everyone involved! https://t.co/joFhs1NwHE
— Hideaki E. Kato (@emeKato) March 26, 2025
(1/n) pic.twitter.com/dZB2K2XUpk
Yuuge paper on #psychedelics The structural diversity of psychedelic drug actions revealed https://t.co/7buwS3kttF
— BryanRoth (@zenbrainest) March 20, 2025
LinkedIN cryo-EM & biotech